John Guy, Manager, Emerging Companies Section Policy at Biotechnology Innovation Organization

Five years ago today, the Protecting Americans from Tax Hikes (PATH) Act was signed into law. This important piece of legislation included several provisions helpful to start ups like small biotechs, including permanently extending both the R&D Credit and the Small Business Stock Gains Exclusion (Tax Code Section 1202), providing both investors and the companies they invest in security without worry of losing access to the critical incentive in the future. 

By: Elaine Bolle, RTP Capital Associates

Rob Neville is a serial entrepreneur, and his story is a powerful testimonial about the importance of angel funding. 

By: Warren Spiwak, IBTX Partner

ACA Affinity Partner IBTX recognizes the risk that angels and startups face.  Now during these unique and extremely challenging times, these risks are more complex then ever before.  IBTX Partner Warren Spiwak recently sat down with ACA to discuss what angels need to be aware of and what the IBTX team of dedicated risk management professionals can do to create innovative solutions to fit the unique needs of the startup ecosystem. 

By: Dror Futter, Legal and Business Adviser to Startups, Venture Capital Firms and Technology Companies

The SEC announced a series of amendments (likely to be effective early next year) to the rules governing private offering exemptions – by far the most frequent path for venture fundraising.  The amendments retain the same “menu” of exemptions but make incremental improvements. For the early stage community, the amendments include a very useful provision that excludes “Demo Days” from being considered general solicitations provided certain conditions are met. 

By: Russ Krajec, CEO of BlueIron

Due diligence is essential for any business deal, and IP due diligence is shockingly left out of the equation for most angel investors and venture capital investors. 

By: Nicholas McKinley, CEO of Verafī

Verafī, ACA’s new Affinity Partner, has a unique background that generates the knowledge and experience to assist angels in completing the valuable due diligence needed to ensure confidence in personal and investment decisions. 

By: Robert Weber, Managing Partner of Great North Ventures, an Upper Midwest Venture Fund

Angel investors and advisors, have you checked in with your tax advisor lately? If not, may I suggest a good reason to do that would be to discuss Section 1202 of the U.S. Tax Code.

By: Pat Gouhin, Chief Executive Officer

The Angel Capital Association’s continued advocacy toward harmonizing and simplifying the existing framework to improve capital raising pathways and expand investment opportunities has yielded successful results for U.S. investors. 

By: Pat Gouhin, Chief Executive Officer

After ACA’s multi-pronged, multi-year advocacy for amendment to the “accredited investor” definition, we are pleased to report we’ve met with success. The Securities and Exchange Commission announced yesterday that the definition of an “accredited investor” has preserved the existing income thresholds and has been expanded to provide more access to private equity by allowing investors to qualify based upon new criteria. 

By: Pat Gouhin, Chief Executive Officer

One of the fundamentals pillars of the Angel Capital Association is protecting and advocating for the rights of angel investors and the entrepreneurs they support. 

Join ACA on Wednesday, September 9, for a special two-part webinar to join subject matter experts from Assure, Carney Badley Spellman, and GrayRobinson as they discuss the current legislative environment as it relates to pending legislation on beneficial ownership and blue sky fees.